The unofficial grey market shows increased activity with rising share prices. Recent strong IPO listings have boosted investor confidence and expectations for future gains. Several upcoming initial public offerings are experiencing significant grey market premiums. This heightened investor appetite is driven by recent successful stock market debuts. Companies are now pricing their offerings more conservatively to ensure strong subscriptions.
Symbiotec Pharmalab sets price band for Rs 1,757 crore IPO, to open on August 24
Symbiotec Pharmalab will launch its ₹1,757-crore IPO from August 24–27, 2026, with a price band of ₹938–988 per share. The minimum bid is 15 shares,